National Trends and Perioperative Outcomes of Robotic‐assisted Hepatectomy in the USA: A Propensity‐score Matched Analysis from the National Cancer Database

Abstract

Background A paucity of data exists on the national use of robotic hepatectomy. We assessed national trends and perioperative outcomes of robotic hepatectomy in the USA. In addition, factors associated with use of the robotic approach were analyzed. Methods The National Cancer Database (NCDB) was queried for patients undergoing hepatectomy from 2010 to 2016. Patients undergoing total hepatectomy for transplant were excluded. Factors associated with the use of the robotic approach were assessed using logistic regression multivariable analysis. Propensity‐score analysis was performed (robotic vs. laparoscopic and robotic vs. open approaches), and perioperative outcomes were compared between the matched groups. Results The robotic approach was used in 287 patients (110 hospitals). Utilization of the robotic approach increased significantly on the national level from 0.8% in 2010 to 4.1% in 2016 (P<0.001). The number of hospitals performing a minimum of one robotic hepatectomy per year increased from 8 in 2010 to 35 in 2016. The median hospital length of stay was 4 days (IQR 3–6), 30‐day readmission rate was 5%, and 30‐day/90‐day mortality rates were 3%/4%. Factors associated with using robotic approach were African‐American race (95% CI 1.02–2.11), recent year of surgery (95% CI 1.11–1.32), HCC histology (95% CI 1.01–52.03), tumor size (95% CI 0.87–0.96), and early‐stage tumor (Stage I‐II, 95% CI 1.27–3.99). On propensity‐matched analysis, there were no differences between robotic and open approaches (n=184 each group) in 30‐day readmission (5% vs. 7%, P=0.651), 30‐day mortality (2% vs. 4%, P=0.106), 90‐day mortality (3% vs. 7%, P=0.080), or 5‐year overall survival (58% vs. 43%, P=0.211). However, the robotic approach was associated with a significantly shorter hospital stay (median: 4 vs. 6 days, P<0.001). There were no differences between matched groups of patients undergoing robotic and laparoscopic approaches (n=182 in each group) in perioperative outcomes or length of hospital stay. Conclusion National use of robotic‐assisted hepatectomy has increased by fivefold over the seven‐year study period. It was associated with a shorter hospital length of stay compared to the open approach without compromising perioperative outcomes or survival.

Practice variation and outcomes of minimally invasive minor liver resections in patients with colorectal liver metastases: a population-based study

“…The superior short-term outcomes observed in this study, such as less blood loss, less postoperative complications, and shorter length of stay, are in line with randomised controlled trials such as the OSLO-COMET[ 26 ] and the LapOpHuva [ 27 ] and with several observational studies [ 28 – 32 ] and a recent meta-analysis [ 33 ]. This study confirmed that the two techniques showed comparable R0 resections and comparable overall survival in the matched cohorts.…”

Persistent poverty impacts access to minimally invasive surgery among patients with hepatopancreatobiliary cancer

“…Additionally, the higher rate of achievement of TO may represent the ability to accomplish better patient care and long‐term outcomes 39 . Previous studies have noted that increasing adoption of MIS to treat HPB cancers over the last decade, leading to an increased rate of achieving TO 20,40 . Collectively, to achieve the best possible outcomes for all patients, it is imperative to implement additional measures that promote equitable access to MIS, particularly for individuals who have been disproportionately affected by long‐standing poverty.…”

Prince and princesses: The current status of robotic surgery in surgical oncology

“…Still, only 2.5% of all hepatectomies, major or minor, were performed robotically. 118 While early results look promising for the future of RH, there are several limitations to the current literature. First, as previously mentioned, no RCTs for primary liver cancer have been published to date.…”

“…From 2010 to 2016, Kamel et al found a significant increase in utilization of RH, from 0.8% to 4.1% ( p < 0.001). Still, only 2.5% of all hepatectomies, major or minor, were performed robotically 118 …”